Masters Pharmaceutical Responds To FDA On Ohio Drug Seizures

Masters Pharmaceutical issued a press release disputing the Food and Drug Administration’s (FDA) position on the raid at Master’s subsidiary RXTPL. The FDA and U.S. Marshalls went to RXTPL’s logistics facility in Fairfield, Ohio on Thursday, May 15, 2014. The government had a search warrant based on a November 2013 inspection at Ascend Laboratories, which showed the use of unapproved drugs. Masters says that RXTPL cooperated with the government in quarantining the drugs at the facility. However, Masters takes issue with the FDA press release that states that Masters was the “distributor” of the drugs because it suggests that Masters is the owner of the drugs.

In its original release, the FDA said, “U.S. Marshals, at the request of the U.S. Food and Drug Administration and the U.S. Attorney for the Southern District of Ohio, have seized more than $11,185,000 worth of unapproved drugs marketed by Ascend Laboratories of Montvale, N.J. and held by Masters Pharmaceuticals, Inc. of Cincinnati, Ohio.”

Dennis Smith, CEO of Masters, said, “We have never and would never knowingly sell unsafe drugs to any customer. The products involved here are not owned or sold by RXTPL.”

Master’s response calls the FDA’s news release “inaccurate, significantly misleading, unfair, and incorrect.” Masters denies that it owns, manufactures, or markets the unapproved drugs. The RXTPL division is a third-party logistics provider for companies without warehousing and distribution facilities. Masters states that RXTPL is just one of many logistics providers across the country. Specifically, Ascend Laboratories rents warehouse space and contracts for staffing, shipping, and other services from RXTPL. Neither Masters nor RXTPL own or market any products at the Ohio facility.

Agreed. It seems millions of dollars worth of pharmaceutical drugs have been seized from a large pharmaceutical co. They say the drugs are illegal. I always port interesting articles like these because you won’t find them anywhere else.

This should have been national news, and the fact that is wasn’t stinks.

It appear there are numerous “pharmaceutical” companies in the US, manufacturing generic Narcotics.

I research links back to creeps like Soros to see what happens and it seems that in addition to us inning the US military to support heroin cartels such as The Muslim Brotherhood, and distributors such as Sinaloa, the FDA is,supporting rogue pharmaceutical companies that are dealing Rx drugs.

Example this company that makes generic OxyContin, who Soros happened to invest in before his Boy, got into the White House.

“George Soros purchased 17531 shares of Mylan Laboratories Inc. between December 31, 2007 and March 31, 2008.”

http://caps.fool.com/Pitch/MYL/2691389/george-soros-purchased-17531-s.aspx

The FDA is obviously as ridiculously corrupt as the SEC, the only difference being our children rely on the doctors that rely on that agency. Take care of your families.

380 Centennial Avenue Centennial Park , Elstree , , WD6 3TJ , United Kingdom
www.mastersint.com
Phone: 44 2083 270 900
Revenue: $30M
Industry: Wholesale Drugs & Pharmacy Supplies
Employees: 70
SIC: Wholesale-Misc Durable Goods (5090)
NAICS: Industrial Supplies Merchant Wholesalers (423840)
2014-04-01 09:01:07
Contacts - VIEW DETAILS

Chief Executive Officer

Dave Moran, CEO
Lynda Foster, CEO
Other

Bill Burns, Chairman
Suzad Masters, Director
Shilpa Gohil, Head of Regulatory Affairs
David Hammond, Pharmaceutical Manager
Daniela Carraro, Regional Sales Manager, Latin America
GM/Managing Director(s)

Roger Schmid, General Manager, Asia
Guisela Fabian, General Manager, Central America
Director(s)

Andrew Elder, Non-executive Board Director

Masters Pharmaceutical, Inc., doing business as DBS Trading, Inc., operates as a wholesale distributor of pharmaceutical and medical products for pharmacies in the United States. The company was formerly known as DBS Trading, Inc. and changed its name to Masters Pharmaceutical, Inc. in May 2006. Masters Pharmaceutical, Inc. was founded in 2000 and is based in Cincinnati, Ohio.

11930 Kemper Springs Drive
Cincinnati, OH 45240
United States

Founded in 2000
Phone:
513-354-2690
Fax:
513-354-2691
www.mastersrx.com

Or it could be a case of an abusive government taking out competition, extortion, or ineptness.

_____________

Enlarge Photo
Slawomir Fajer
U.S. Marshals and the FDA have seized $11 million in drugs that sit in Norwood-based Masters Pharmaceuticals’ warehouse. The company says it is not at fault.

Lisa Benson
Managing Editor-
Cincinnati Business Courier

The general counsel for Masters Pharmaceutical had sharp criticism for the Food and Drug Administration today after the agency announced it quarantined millions in drugs from its Fairfield warehouse.
Rick Lauer, general counsel and vice president of strategy acquisitions, called the statement issued by the FDA”unfortunate and misleading.”
“The product seized by the FDA does not belong to Masters,” he said. “We are a third-party logistics provider.”

The products belong to Ascend Laboratories of Montvale, N.J., which rents warehouse space from Masters. The drugs include Pramoxine-HC Otic Drops, intended to treat infections of the external ear; Hydrocortisone Acetate Suppositories 25 mg, intended to treat inflammatory conditions; and Urea Cream 39%, Urea Cream 40% and Urea Lotion 40%, intended to treat conditions such as dermatitis and eczema.
A representative from Ascend Laboratories could not be reached for comment.

“We are being treated worse than the actual liable party here. It is the manufacturer who is ultimately responsible that they are manufucturing an approved product,” Lauer said.

FDA spokesman Christopher Kelly refused to discuss the agency’s statement.
“We stand by the press release,” he said. “We don’t have anything further to comment on.”

Lauer said the company has been flooded with calls from its bankers and customers after news organizations picked up the press release from the FDA, which prominently names Masters as involved in the seizure.
“We are not a target of the investigation,” said Lauer. “We are not responsible for making sure (these kinds of drugs) in our warehouse are approved.”

Lauer stressed that there is no financial impact to Masters as a result of the raid. The company is operating as normally, and the product in question has been quarantined.

“Our only issue with the FDA is that their press release was misleading. It implies the product is owned by us and was seized from us. That is not accurate. It is owned by Ascend and was seized from Ascend,” he said.
Benson manages day-to-day operations of print and web products
Related links: Food
Industries: Human Resources

Disclaimer: Opinions posted on Free Republic are those of the individual posters and do not necessarily represent the opinion of Free Republic or its management. All materials posted herein are protected by copyright law and the exemption for fair use of copyrighted works.